Riccardo Pagni - Academia.edu (original) (raw)

Uploads

Papers by Riccardo Pagni

Research paper thumbnail of Glansectomy with split-thickness skin graft for the treatment of penile carcinoma

International Journal of Impotence Research, 2009

Research paper thumbnail of Long-term Functional Outcomes in Patients With a W-shaped Ileal Orthotopic Neobladder With No Antireflux Mechanism

Research paper thumbnail of 2012 Vardenafil Mediated Image Amplification in Power Doppler Ultrasound Diagnostics of Prostatic Diseases

Research paper thumbnail of Effects on renal function of obstructive and nonobstructive dilatation of the upper urinary tract in ileal neobladders with refluxing ureteroenteric anastomoses

European Journal of Surgical Oncology (EJSO), 2010

Research paper thumbnail of Treatment With Intraoperative Patent Blue V Dye of Refractory Lymphocele After Inguinal Lymphadenectomy for Squamous Cell Penile Carcinoma

Urology, 2009

To evaluate the potential curative role of the intraoperative use of a dye, the Patent Blue V, fo... more To evaluate the potential curative role of the intraoperative use of a dye, the Patent Blue V, for the treatment of refractory lymphoceles by mapping the lymphatic leakage and selectively ligating the opened lymphatics. Inguinal lymphocele is a well-known complication after inguinofemoral lymph node dissection for penile cancer, and a variety of curative approaches have been reported. From 1995 to 2007, 40 patients had undergone partial or total penectomy for squamous cell cancer. Superficial inguinal lymph node dissection with saphenous vein sparing or deep lymph node dissection was performed in 15 patients. It was unilateral in 14 and bilateral in 1 patient. When the lymphoceles were refractory to conventional therapy, ligation of the lymphatic vessels after mapping of the leakage with the Patent Blue V dye was the treatment of choice. Overall, 5 lymphoceles were detected in 4 patients that were continuously increasing in size after discharge and were treated conventionally. In the 2 refractory lymphoceles, we then opted for the intraoperative use of a dye, the Patent Blue V, to map the lymphatic leakage and selectively ligate the opened lymphatics. In both cases, complete resolution of the lymphoceles occurred. No complications were observed with this technique. The presented technique is able to cure persistent lymphoceles refractory to conventional treatment after inguinal lymph node dissection.

Research paper thumbnail of Glansectomy with split-thickness skin graft for the treatment of penile carcinoma

International Journal of Impotence Research, 2009

Research paper thumbnail of Long-term Functional Outcomes in Patients With a W-shaped Ileal Orthotopic Neobladder With No Antireflux Mechanism

Research paper thumbnail of 2012 Vardenafil Mediated Image Amplification in Power Doppler Ultrasound Diagnostics of Prostatic Diseases

Research paper thumbnail of Effects on renal function of obstructive and nonobstructive dilatation of the upper urinary tract in ileal neobladders with refluxing ureteroenteric anastomoses

European Journal of Surgical Oncology (EJSO), 2010

Research paper thumbnail of Treatment With Intraoperative Patent Blue V Dye of Refractory Lymphocele After Inguinal Lymphadenectomy for Squamous Cell Penile Carcinoma

Urology, 2009

To evaluate the potential curative role of the intraoperative use of a dye, the Patent Blue V, fo... more To evaluate the potential curative role of the intraoperative use of a dye, the Patent Blue V, for the treatment of refractory lymphoceles by mapping the lymphatic leakage and selectively ligating the opened lymphatics. Inguinal lymphocele is a well-known complication after inguinofemoral lymph node dissection for penile cancer, and a variety of curative approaches have been reported. From 1995 to 2007, 40 patients had undergone partial or total penectomy for squamous cell cancer. Superficial inguinal lymph node dissection with saphenous vein sparing or deep lymph node dissection was performed in 15 patients. It was unilateral in 14 and bilateral in 1 patient. When the lymphoceles were refractory to conventional therapy, ligation of the lymphatic vessels after mapping of the leakage with the Patent Blue V dye was the treatment of choice. Overall, 5 lymphoceles were detected in 4 patients that were continuously increasing in size after discharge and were treated conventionally. In the 2 refractory lymphoceles, we then opted for the intraoperative use of a dye, the Patent Blue V, to map the lymphatic leakage and selectively ligate the opened lymphatics. In both cases, complete resolution of the lymphoceles occurred. No complications were observed with this technique. The presented technique is able to cure persistent lymphoceles refractory to conventional treatment after inguinal lymph node dissection.

Log In